Qianyuan Pharmaceutical: The company has a drug approval for silybin meglumine tablets, which can be used for the adjuvant treatment of acute and chronic hepatitis, initial cirrhosis, and toxic liver damage

Post date April 29, 2022 — 18:22 Post Lock

Key Data Concepts:
? These are the company names, stock quotes, topics, and entities related to this data.

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Related Data

63 A-share chips changed hands (May 20) _ Oriental Fortune Net

May 20, 2022 — 17:50

Ang Likang: The cumulative number of pledged shares of Shengzhou Juntai Investment Co., Ltd. is 16.77 million shares_ Oriental Fortune Net

May 20, 2022 — 17:46

Experimental monkey trapped in time-Titanium Media Official Website

May 20, 2022 — 16:55

"I don't think it's unusual for a monkey to rise to 200,000"

May 20, 2022 — 16:55

"Experimental Monkey" interface news trapped in time JMedia

May 20, 2022 — 16:41

Zhongsheng Pharmaceutical was investigated by 13 institutions: Fufang Xueshuantong Capsule and Naoshuantong Capsule strengthened evidence-based evidence through medical research and obtained high-quality clinical research results (with survey questions and answers)

May 20, 2022 — 16:00

A number of companies have clarified that "there is no fenugreek"! Beware of second-degree speculation in risk concept stocks_Sina Finance_Sina.com

May 17, 2022 — 15:02

A number of companies have clarified that "there is no fenugreek"! Beware of the risk of second-degree speculation CFi.CN Zhongcai Network

May 17, 2022 — 14:57

Jingxin Pharmaceutical: The company's innovative projects are progressing in an orderly manner, and it is expected that they will be approved for listing in the next year and the next.

May 17, 2022 — 14:32

Home » News » Qianyuan Pharmaceutical: The company has a drug approval for silybin meglumine tablets, which can be used for the adjuvant treatment of acute and chronic hepatitis, initial cirrhosis, and toxic liver damage